Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil for oxaliplatin-induced peripheral neuropathy in colorectal cancer survivors
2021-005326-23Phase 2Completed
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in peripheral neuropathy (CIPN) comparing Donepezil with Placebo (2 arms). Primary endpoint: QLQ-CIPN20 sensory responder rate. Started Nov 2021; status: completed.
02
Drugs
donepezil
03
Conditions
peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on 2021-005326-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-005326-23.